Haoxi Health Technology Limited (HAO)

Haoxi Health Technology Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	32.8	48.52	28.23	16.16	12.85
Revenue Growth (YoY)	-32.39%	71.88%	74.72%	25.76%	-
Cost of Revenue	31.88	45.77	26.17	15.51	-12.24
Gross Profit	0.93	2.75	2.06	0.65	0.61
Selling, General & Admin	2.85	0.95	0.81	0.28	0.21
Research & Development	0.08	0.08	0.06	0.1	0.06
Total Operating Expenses	2.93	1.03	0.87	0.38	0.28
Operating Income	-2	1.72	1.2	0.27	0.33
Interest Income	0.36	0.08	-	-	-
Interest Expense	-0.05	-0.04	-0.02	-0.01	-
Other Non-Operating Income (Expense)	5.83	-0.02	0.02	0	-0.01
Total Non-Operating Income (Expense)	6.15	0.02	-0.01	-0.01	-0.01
Pretax Income	4.15	1.74	1.19	0.26	0.33
Provision for Income Taxes	0.27	0.44	0.22	0.02	0.02
Net Income	3.88	1.29	0.97	0.24	0.3
Net Income to Common	3.88	1.29	0.97	0.24	0.3
Net Income Growth	200.13%	33.20%	296.49%	-19.56%	-
Shares Outstanding (Basic)	2	1	1	1	1
Shares Outstanding (Diluted)	2	1	1	1	1
Shares Change (YoY)	95.84%	10.82%	10.45%	-	-
EPS (Basic)	1.66	1.06	0.87	0.25	0.30
EPS (Diluted)	1.32	1.06	0.87	0.25	0.30
EPS Growth	24.53%	21.84%	248.00%	-16.67%	-
Free Cash Flow	-3.36	-0.8	-0.92	-0.68	2.65
Free Cash Flow Per Share	-1.40	-0.66	-0.83	-0.68	2.65
Gross Margin	2.83%	5.67%	7.30%	4.02%	4.71%
Operating Margin	-6.10%	3.54%	4.24%	1.66%	2.57%
Profit Margin	11.82%	2.66%	3.44%	1.51%	2.37%
FCF Margin	-10.24%	-1.65%	-3.25%	-4.23%	20.59%
EBITDA	-1.63	1.73	1.2	0.27	0.33
EBITDA Margin	-4.96%	3.56%	4.27%	1.68%	2.58%
EBIT	-2	1.72	1.2	0.27	0.33
EBIT Margin	-6.10%	3.54%	4.24%	1.66%	2.57%
Effective Tax Rate	6.53%	25.56%	18.54%	5.78%	6.52%

Updated Oct 20, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q